Results 1 to 10 of about 240 (81)

Noopept protects ciliates Paramecium сaudatum cells from the toxic effects of heavy metal compounds [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
Background. The dipeptide drug Noopept, created at the Zakusov Institute of Pharmacology, has a wide range of pharmacological actions, including cytoprotective one.
O. V. Karpukhina   +2 more
doaj   +5 more sources

Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
The article presents the results of studying the pharmacokinetics and enzymatic stability of a new pharmacologically active compound GZK-111– N-phenylacetyl-glycyl-L-proline ethyl ether in comparison with noopept – N-phenylacetyl-L-prolyl-glycine ethyl ...
S. S. Boyko   +2 more
doaj   +5 more sources

Morpho-functional parameters of neurons in the sensorimotor cortex and neuroapoptosis under conditions of an induced experimental allergic encephalomyelitis in rats and a course of intranasal gel administration containing n-phenylacetyl-l-prolylglycine (N [PDF]

open access: yesJournal of Education, Health and Sport, 2021
Purpose. The aim of the research is to evaluate a neuroprotective effect of the nasal dosage form containing Noopept (n-phenylacetyl-l-prolylglycine ethyl ester) by the degree of influence on morphofunctional parameters of neurons in the sensorimotor ...
B. S. Burlaka   +3 more
doaj   +3 more sources

Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process

open access: yesHeliyon, 2021
There are largely unknown associations between changes in pain behavior responses during persistent peripheral inflammation and spinal cell alteration such as apoptosis.
Mona Taghizadeh   +8 more
doaj   +2 more sources

Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
The review presents the results of studies on the pharmacokinetics, metabolism, and bioavailability of new neurotropic dipeptide cyclo-Lprolilglycine (CPG) and their pharmacological activity.
S. S. Boyko   +2 more
doaj   +5 more sources

A study on toxicity, local irritative effect of and allergic response to a novel intranasal medication containing N-phenylacetyl-L-prolylglycine ethyl ester [PDF]

open access: yesZaporožskij Medicinskij Žurnal, 2021
Development of novel medications for delivery of active ingredients with systemic absorption and high bioavailability is an actual challenge for modern pharmaceutical and medical science.
B. S. Burlaka, I. F. Bielenichev
doaj   +3 more sources

Neuroprotective properties of n-phenylacetyl-l-prolylglycine ethyl ester nasal gel in an experimental model of multiple sclerosis equivalent [PDF]

open access: yesMedičnì Perspektivi, 2020
The purpose of this research is to study the specific activity of our developed nasal dosage form with n-phenylacetyl-l-prolylglycine ethyl ester. The experiments were performed on 260 white outbred rats weighing 190-220 g.
B.S. Burlaka   +4 more
doaj   +4 more sources

Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2019
While studing of experimental pharmacokinetics of the peptide analogues piracetam noopept - N-phenylacetyl-L-prolyl-glycine ethyl ester, was found the active metabolite that identificated as cyclo-L-prolylglycine (CPG).
Svetlana Boyko   +2 more
doaj   +3 more sources

The study of the permeability of the blood-brain barrier for new neurotropic peptide drugs [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2019
The paper presents the results of studies of penetration through the hemato-encephalic barrier (BBB) of rats of three new peptide drugs -modified analogues of endogenous neuropeptides and their active metabolites created in the research Zakusov institute
V. P. Zherdev   +2 more
doaj   +5 more sources

The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control Laboratories [PDF]

open access: yesJournal of Xenobiotics
In recent years, an increasing number of case reports have mentioned the presence of illicit nootropics, smart drugs or mind doping products on the market.
Celine Vanhee   +18 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy